Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ARYDNASDAQ:DNADNASDAQ:FHLTNASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARYDARYA Sciences Acquisition Corp IV$6.64-25.9%$8.77$6.25▼$11.57$50.07MN/A40,002 shs94,400 shsDNADSocial Capital Suvretta Holdings Corp. IV$10.35$10.34$9.70▼$10.92$330.06M0.02151,123 shs144,200 shsFHLTFuture Health ESG$10.96$11.25$10.10▼$15.05$65.10MN/AN/AN/APREPrenetics Global$10.05+0.2%$5.26$3.09▼$11.99$122.66M-0.2618,891 shs18,974 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARYDARYA Sciences Acquisition Corp IV0.00%0.00%0.00%0.00%-41.60%DNADSocial Capital Suvretta Holdings Corp. IV0.00%0.00%0.00%0.00%0.00%FHLTFuture Health ESG0.00%0.00%0.00%0.00%0.00%PREPrenetics Global-2.72%+37.40%+98.50%+95.52%+74.13%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARYDARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/AN/AN/AN/ADNADSocial Capital Suvretta Holdings Corp. IVN/AN/AN/AN/AN/AN/AN/AN/AFHLTFuture Health ESGN/AN/AN/AN/AN/AN/AN/AN/APREPrenetics Global1.606 of 5 stars1.55.00.00.03.60.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARYDARYA Sciences Acquisition Corp IV 0.00N/AN/AN/ADNADSocial Capital Suvretta Holdings Corp. IV 0.00N/AN/AN/AFHLTFuture Health ESG 0.00N/AN/AN/APREPrenetics Global 3.00Buy$9.00-10.45% DownsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARYDARYA Sciences Acquisition Corp IVN/AN/AN/AN/A($3.49) per shareN/ADNADSocial Capital Suvretta Holdings Corp. IVN/AN/A$0.09 per share120.59($0.23) per shareN/AFHLTFuture Health ESGN/AN/AN/AN/A($1.56) per shareN/APREPrenetics Global$30.62M4.01N/AN/A$17.22 per share0.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARYDARYA Sciences Acquisition Corp IV-$2.13MN/A0.00∞N/AN/AN/A-6.48%N/ADNADSocial Capital Suvretta Holdings Corp. IV$2.74MN/A0.00∞N/AN/A-73.34%2.13%N/AFHLTFuture Health ESG-$50KN/A0.00∞N/AN/AN/AN/AN/APREPrenetics Global-$62.72M-$3.99N/AN/AN/A-191.73%-16.45%-13.34%6/17/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARYDARYA Sciences Acquisition Corp IVN/AN/AN/AN/AN/ADNADSocial Capital Suvretta Holdings Corp. IVN/AN/AN/AN/AN/AFHLTFuture Health ESGN/AN/AN/AN/AN/APREPrenetics Global$2.8027.86%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARYDARYA Sciences Acquisition Corp IVN/A0.010.01DNADSocial Capital Suvretta Holdings Corp. IVN/A1.011.01FHLTFuture Health ESGN/AN/AN/APREPrenetics GlobalN/A1.401.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARYDARYA Sciences Acquisition Corp IV48.08%DNADSocial Capital Suvretta Holdings Corp. IV77.11%FHLTFuture Health ESG24.57%PREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipARYDARYA Sciences Acquisition Corp IV53.45%DNADSocial Capital Suvretta Holdings Corp. IVN/AFHLTFuture Health ESG57.20%PREPrenetics Global7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARYDARYA Sciences Acquisition Corp IV37.54 million3.51 millionNot OptionableDNADSocial Capital Suvretta Holdings Corp. IV431.89 millionN/ANot OptionableFHLTFuture Health ESG2,0215.94 million2.54 millionNot OptionablePREPrenetics Global112.21 million11.25 millionNot OptionableDNAD, FHLT, PRE, and ARYD HeadlinesRecent News About These CompaniesPrenetics Global (NASDAQ:PRE) Shares Down 2.6% - Should You Sell?May 15, 2025 | marketbeat.comPrenetics Global Full Year 2024 Earnings: Misses ExpectationsMay 3, 2025 | finance.yahoo.comPrenetics Global Limited (PRENW)March 19, 2025 | ca.finance.yahoo.comPrenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements MarketMarch 18, 2025 | markets.businessinsider.comPrenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements MarketMarch 18, 2025 | globenewswire.comPrenetics to Participate in the 37th Annual ROTH ConferenceMarch 11, 2025 | finance.yahoo.comPrenetics Reports Strong 2024 Results and Optimistic 2025 OutlookMarch 5, 2025 | tipranks.comPrenetics Global Limited Reports 93.5% Revenue Growth in Q4 2024 and Provides 2025 Financial GuidanceMarch 5, 2025 | quiverquant.comPrenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 GuidanceMarch 5, 2025 | globenewswire.comNYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPOFebruary 14, 2025 | prnewswire.comPrenetics Global Ltd trading resumesFebruary 12, 2025 | markets.businessinsider.comPrenetics Global Ltd trading halted, volatility trading pauseFebruary 12, 2025 | markets.businessinsider.comPrenetics partners with Humanity Protocol, launches crypto strategic reserveFebruary 11, 2025 | markets.businessinsider.comPrenetics Partners with Humanity Protocol to Enhance Blockchain-Based Identity Verification and Invests in Digital AssetsFebruary 11, 2025 | quiverquant.comNasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic ReserveFebruary 11, 2025 | globenewswire.comPrenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David BeckhamJanuary 22, 2025 | markets.businessinsider.comCantor Fitzgerald Sticks to Their Buy Rating for Prenetics Group (PRE)January 16, 2025 | markets.businessinsider.comIM8, Co-Founded by David Beckham, Achieves NSF Certified for Sport® Certification for Daily Ultimate Essentials SupplementJanuary 15, 2025 | quiverquant.comPrenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate EssentialsJanuary 15, 2025 | globenewswire.comDavid Beckham Joins Prenetics as Strategic Investor for IM8 Health BrandJanuary 14, 2025 | lawyer-monthly.comHow David Beckham plans to win the $152 billion supplements businessJanuary 14, 2025 | fastcompany.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumNVIDIA’s AI Robot Leap: 2 Stocks Set to Ride the WaveBy Nathan Reiff | May 23, 2025View NVIDIA’s AI Robot Leap: 2 Stocks Set to Ride the WaveAfter Earnings Beats, These 3 Stocks Are on Analysts’ RadarsBy Leo Miller | May 20, 2025View After Earnings Beats, These 3 Stocks Are on Analysts’ RadarsUPS Stock Forecast: Rebound Underway for United Parcel Service?By Thomas Hughes | May 4, 2025View UPS Stock Forecast: Rebound Underway for United Parcel Service?MercadoLibre Is Soaring—Should You Wait for a Better Entry?By Ryan Hasson | May 26, 2025View MercadoLibre Is Soaring—Should You Wait for a Better Entry?DNAD, FHLT, PRE, and ARYD Company DescriptionsARYA Sciences Acquisition Corp IV NASDAQ:ARYDArya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors. The company was incorporated in 2020 and is based in New York, New York.Social Capital Suvretta Holdings Corp. IV NASDAQ:DNADSocial Capital Suvretta Holdings Corp. IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology industry. Social Capital Suvretta Holdings Corp. IV was incorporated in 2021 and is based in Henderson, Nevada.Future Health ESG NASDAQ:FHLTFuture Health ESG Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Dover, Delaware.Prenetics Global NASDAQ:PRE$10.05 +0.02 (+0.20%) Closing price 03:51 PM EasternExtended Trading$10.09 +0.04 (+0.40%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
